{
  "id": 2451798,
  "title": "Quantum Biopharma Provides Corporate Update",
  "url": "https://urgent.news/2026/08/21/quantum-biopharma-provides-corporate-update",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-21T23:00:49.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/quantum-biopharma-provides-corporate-update-7"
  },
  "original_language": "en",
  "account": null,
  "summary": "THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 21, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum” or the “Company“), a biopharmaceutical company dedicated to building a portfolio […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}